Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
16.93
-0.48 (-2.76%)
At close: May 30, 2025, 3:59 PM
16.80
-0.77%
After-hours: May 30, 2025, 05:56 PM EDT
Apellis Pharmaceuticals Revenue
Apellis Pharmaceuticals reported an annual revenue of $781.37M, reflecting a 97.02% growth. For the quarter ending March 31, 2025, Apellis Pharmaceuticals generated $166.8M in revenue.
Revenue (ttm)
$781.37M
Revenue Growth
97.02%
Price / Sales Ratio
5.06
Revenue / Employee
$1.11M
Employees
705
Market Cap
2.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|